Moreover, a tolerogenic status may predominate early in the pathological process as suggested by the tendency to increased levels of TGF-β and PD-L1 mRNA in liver samples from patients with PBC at stages I-II as compared with late-stage samples [32]. This evidence concerns the gene TGFB1 and primary biliary cholangitis.